in-cell NMR法による細胞内RASの活性型割合の観測とその制御機構の解明

1.

Wennerberg, K., Rossman, K. L. & Der, C. J. The Ras superfamily at a glance. J. Cell Sci. 118,

843–846 (2005).

2.

Milburn, M. V. et al. Molecular switch for signal transduction: structural differences between

active and inactive forms of protooncogenic ras proteins. Science 247, 939–945 (1990).

3.

Simanshu, D. K., Nissley, D. V. & McCormick, F. RAS Proteins and Their Regulators in Human

Disease. Cell 170, 17–33 (2017).

4.

Prior, I. A., Lewis, P. D. & Mattos, C. A Comprehensive Survey of Ras Mutations in Cancer.

Cancer Res. 72, 2457–2467 (2012).

5.

Pai, E. F. et al. Refined crystal structure of the triphosphate conformation of H-ras p21 at 1.35 A

resolution: implications for the mechanism of GTP hydrolysis. EMBO J. 9, 2351–2359 (1990).

6.

Hobbs, G. A., Der, C. J. & Rossman, K. L. RAS isoforms and mutations in cancer at a glance. J.

Cell Sci. 129, 1287–1292 (2016).

7.

Ahearn, I. M., Haigis, K., Bar-Sagi, D. & Philips, M. R. Regulating the regulator: posttranslational modification of RAS. Nat. Rev. Mol. Cell Biol. 13, 39–51 (2012).

8.

Gorfe, A. A., Grant, B. J. & McCammon, J. A. Mapping the nucleotide and isoform dependent

structural and dynamical features of Ras proteins. Struct. Lond. Engl. 1993 16, 885–896 (2008).

9.

Marshall, C. B. et al. Probing the GTPase cycle with real-time NMR: GAP and GEF activities in

cell extracts. Methods 57, 473–485 (2012).

10. Smith, M. J., Neel, B. G. & Ikura, M. NMR-based functional profiling of RASopathies and

oncogenic RAS mutations. Proc. Natl. Acad. Sci. 110, 4574–4579 (2013).

11. Young, A., Lou, D. & McCormick, F. Oncogenic and Wild-type Ras Play Divergent Roles in the

Regulation of Mitogen-Activated Protein Kinase Signaling. Cancer Discov. 3, 112–123 (2013).

12. Bollag, G. & McCormick, F. Differential regulation of rasGAP and neurofibromatosis gene

product activities. Nature 351, 576–579 (1991).

13. Boriack-Sjodin, P. A., Margarit, S. M., Bar-Sagi, D. & Kuriyan, J. The structural basis of the

activation of Ras by Sos. Nature 394, 337–343 (1998).

14. Taylor, S. J., Resnick, R. J. & Shalloway, D. Nonradioactive determination of Ras-GTP levels

using activated ras interaction assay. in Methods in Enzymology vol. 333 333–342 (Academic

Press, 2001).

15. Luchinat, E. & Banci, L. In-cell NMR: a topical review. IUCrJ 4, 108–118 (2017).

81

16. Serber, Z. et al. High-Resolution Macromolecular NMR Spectroscopy Inside Living Cells. J. Am.

Chem. Soc. 123, 2446–2447 (2001).

17. Sakakibara, D. et al. Protein structure determination in living cells by in-cell NMR spectroscopy.

Nature 458, 102–105 (2009).

18. Selenko, P. et al. In situ observation of protein phosphorylation by high-resolution NMR

spectroscopy. Nat. Struct. Mol. Biol. 15, 321–329 (2008).

19. Inomata, K. et al. High-resolution multi-dimensional NMR spectroscopy of proteins in human

cells. Nature 458, 106–109 (2009).

20. Theillet, F.-X. et al. Structural disorder of monomeric α-synuclein persists in mammalian cells.

Nature 530, 45–50 (2016).

21. Kubo, S. et al. A Gel-Encapsulated Bioreactor System for NMR Studies of Protein–Protein

Interactions in Living Mammalian Cells. Angew. Chem. Int. Ed. 52, 1208–1211 (2013).

22. Mochizuki, A. et al. Balanced Regulation of Redox Status of Intracellular Thioredoxin Revealed

by in-Cell NMR. J. Am. Chem. Soc. 140, 3784–3790 (2018).

23. Zhao, Q. et al. Real-Time In-Cell NMR Reveals the Intracellular Modulation of GTP-Bound

Levels of RAS. Cell Rep. 32, 108074 (2020).

24. Ogino, S. et al. Observation of NMR Signals from Proteins Introduced into Living Mammalian

Cells by Reversible Membrane Permeabilization Using a Pore-Forming Toxin, Streptolysin O. J.

Am. Chem. Soc. 131, 10834–10835 (2009).

25. Schanda, P., Kupče, Ē. & Brutscher, B. SOFAST-HMQC Experiments for Recording Twodimensional Deteronuclear Correlation Spectra of Proteins within a Few Seconds. J. Biomol.

NMR 33, 199–211 (2005).

26. Tugarinov, V., Hwang, P. M., Ollerenshaw, J. E. & Kay, L. E. Cross-Correlated Relaxation

Enhanced 1H−13C NMR Spectroscopy of Methyl Groups in Very High Molecular Weight

Proteins and Protein Complexes. J. Am. Chem. Soc. 125, 10420–10428 (2003).

27. Mazhab-Jafari, M. T. et al. Oncogenic and RASopathy-associated K-RAS mutations relieve

membrane-dependent occlusion of the effector-binding site. Proc. Natl. Acad. Sci. 112, 6625–

6630 (2015).

28. Small, E. & Addinall, S. G. Dynamic FtsZ polymerization is sensitive to the GTP to GDP ratio

and can be maintained at steady state using a GTP-regeneration system. Microbiology, 149, 2235–

2242 (2003).

82

29. Scheffzek, K. et al. The Ras-RasGAP Complex: Structural Basis for GTPase Activation and Its

Loss in Oncogenic Ras Mutants. Science 277, 333–339 (1997).

30. Cherfils, J. & Zeghouf, M. Regulation of Small GTPases by GEFs, GAPs, and GDIs. Physiol.

Rev. 93, 269–309 (2013).

31. Ellis, R. J. Macromolecular crowding: obvious but underappreciated. Trends Biochem. Sci. 26,

597–604 (2001).

32. Pocker, Y. & Janjic, N. Enzyme kinetics in solvents of increased viscosity. Dynamics aspects of

carbonic anhydrase catalysis. Biochemistry 26, 2597–2606 (1987).

33. Klockow, B., Ahmadian, M. R., Block, C. & Wittinghofer, A. Oncogenic insertional mutations in

the P-loop of Ras are overactive in MAP kinase signaling. Oncogene 19, 5367–5376 (2000).

34. Yu, I. et al. Biomolecular interactions modulate macromolecular structure and dynamics in

atomistic model of a bacterial cytoplasm. eLife 5, e19274 (2016).

35. Scheffzek, K. & Shivalingaiah, G. Ras-Specific GTPase-Activating Proteins—Structures,

Mechanisms, and Interactions. Cold Spring Harb. Perspect. Med. 9, a031500 (2019).

36. Davey, J. R. et al. TBC1D13 is a RAB35 Specific GAP that Plays an Important Role in GLUT4

Trafficking in Adipocytes. Traffic 13, 1429–1441 (2012).

37. Pan, F. et al. Feedback inhibition of calcineurin and Ras by a dual inhibitory protein Carabin.

Nature 445, 433–436 (2007).

38. Gavriljuk, K. et al. Catalytic mechanism of a mammalian Rab·RabGAP complex in atomic detail.

Proc. Natl. Acad. Sci. 109, 21348–21353 (2012).

39. Janes, M. R. et al. Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor.

Cell 172, 578-589.e17 (2018).

40. Canon, J. et al. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity.

Nature 575, 217–223 (2019).

41. Lee, K.-Y. et al. Two Distinct Structures of Membrane-Associated Homodimers of GTP- and

GDP-Bound KRAS4B Revealed by Paramagnetic Relaxation Enhancement. Angew. Chem. Int.

Ed. 59, 11037–11045 (2020).

42. Uhlen, M. et al. A pathology atlas of the human cancer transcriptome. Science 357, (2017).

83

謝辞

本論文を作成するにあたり、本研究課題を行う貴重な機会とそのための最高の環境を与

えて下さり、また、数多くの大変貴重で的確な御指導、御助言、および励ましの御言葉を賜

りました、東京大学大学院薬学系研究科 生命物理化学教室 嶋田一夫 前教授 (現 国立研

究開発法人理化学研究所 生命機能科学研究センター チームリーダー)に深く感謝致します。

本研究を遂行するにあたり、常に正しい方向を示し続けて下さり、研究活動の様々な面で

密接な御指導を直接賜りました、東京大学大学院薬学系研究科

紀貴 前准教授 (現 千葉大学大学院

生命物理化学教室

西田

薬学系研究院 薬品物理化学研究室 教授)に深く感謝

致します。

本研究に関して、セミナーなどを通じて多くの御助言を下さり、本研究がより良い内容と

なるように御支援いただきました、東京大学大学院薬学系研究科

生命物理化学教室

田卓見 准教授、幸福裕 助教に深く感謝致します。

本研究の実施にあたり、私の直属の先輩として細胞内に導入した RAS の in-cell NMR 観

測における様々な実験手法の基礎を築いていただいた東京大学大学院薬学系研究科

生命

物理化学教室 藤宮 瑠勇 修士に深く感謝いたします。

さらに研究に対して適切なご助言やご意見を頂けるだけでなく、研究生活を送る上で

様々な形でお世話になりました、東京大学大学院薬学系研究科

生命物理化学教室の皆様

に深く感謝致します。

最後に、これまでの２７年間の長い間にわたって私を温かく見守り、支援してくださった

家族に心より感謝いたします。

84

...